Log In
Print this Print this

sulfatinib (HMPL-012)

  Manage Alerts
Collapse Summary General Information
Company Hutchison China MediTech Ltd.
DescriptionSelective tyrosine kinase inhibitor of VEGF and fibroblast growth factor (FGF) receptor (FGFR)
Molecular Target Vascular endothelial growth factor (VEGF) ; Fibroblast growth factor (FGF) receptor (FGFR)
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor; Fibroblast growth factor (FGF) receptor 1 (FGFR1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today